We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Focal Laser Ablation (FLA), an emerging treatment for localized prostate cancer that uses heat to destroy cancer cells while preserving healthy tissue. Learn about the procedure, effectiveness, risks, and when it might be recommended.

Prostate cancer is a significant health concern for many men, and advancements in treatment are always sought after. One such emerging treatment is Focal Laser Ablation (FLA), a minimally invasive procedure that uses heat generated by a laser to destroy cancer cells. This approach aims to target only the cancerous areas, preserving the healthy prostate tissue and potentially reducing the side effects associated with traditional treatments like surgery or radiation therapy.
Focal Laser Ablation (FLA) is a type of focal therapy for prostate cancer. Focal therapies are designed to precisely target and eliminate cancer cells while leaving the surrounding healthy organ tissue undamaged. In FLA, a concentrated beam of light is used to generate heat, which effectively destroys the cancerous cells. The goal is to treat the cancer effectively while minimizing damage to the rest of the prostate, which is crucial for maintaining functions like urinary control and sexual health.
FLA is primarily considered for a specific subset of prostate cancers. It is most suitable for cancers that are localized to a single area within the prostate gland. It is estimated that only about 15–20% of prostate cancers are confined to one part of the prostate and are thus potential candidates for focal therapies like FLA. These are often intermediate-risk prostate cancers. While promising, FLA is still considered an experimental option by many medical bodies due to the limited amount of comparative research available. Organizations like the American Urological Association and the National Comprehensive Cancer Network do not routinely recommend FLA in their guidelines because of the need for more robust evidence.
The FLA procedure is typically performed under sedation and involves several key steps:
Small studies suggest that FLA is generally safe and associated with a low risk of side effects compared to more invasive treatments. However, it's important to be aware of potential complications. Some reported side effects from clinical trials include:
It is important to note that most studies examining FLA have small sample sizes and relatively short follow-up periods. Therefore, the long-term side effect profile is still being evaluated. A clinical trial that monitored 15 people for 3 years reported no serious side effects, with common issues being mild and temporary.
The effectiveness of FLA is an area of ongoing research. While multiple small studies indicate that MRI-guided FLA can achieve success rates comparable to traditional treatments like surgery or radiation therapy, more extensive research is needed. In one small study involving 120 men with early-stage, low- to intermediate-risk prostate cancer, only 17% required additional treatment within a year of FLA. However, the long-term outcomes and comparisons with established treatments require further investigation. Many clinical trials are currently underway to gather more data on FLA's efficacy and optimal use.
Currently, FLA is not a routine recommendation for prostate cancer treatment due to the limited evidence. Doctors may consider FLA for men with:
It is crucial to discuss the potential benefits, risks, and alternatives with your urologist or oncologist to determine if FLA is the right option for you.
Prostate cancer treatments can be expensive. In the United States, a 2019 study found that half of men over 70 paid more than $14,453 for prostate cancer treatment within three years of diagnosis. While FLA is a newer treatment and its availability is still limited, its cost can vary significantly. As research progresses and the procedure becomes more widespread, cost information may become clearer.
Focal Laser Ablation represents a promising frontier in prostate cancer treatment, offering a more targeted approach with the potential for fewer side effects. However, it is still in its early stages, and extensive clinical trials are ongoing. It may take several years for the results of some of these trials to become available, with some not expected to conclude until 2038. As more data emerges, FLA may become a more established and widely recommended treatment option for eligible patients.
It is essential to consult a doctor if you experience any symptoms of prostate cancer, such as:
Regular screening, especially for men over 50 or those with a family history of prostate cancer, is also highly recommended. Discussing your concerns and potential treatment options, including emerging therapies like FLA, with your healthcare provider is crucial for making informed decisions about your health.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026